C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/18 (2006.01) C07C 251/86 (2006.01) G01N 33/50 (2006.01)
Patent
CA 2109082
2109082 9219722 PCTABS00017 A method is disclosed for predicting response of a tumor patient to therapy, and selecting appropriate therapy for malignant neoplasms such as breast, ovarian and gastrointestinal cancer. A sample of tumor cells is cultured in the presence of 10 µg/ml estradiol, and inhibition of cell growth in the culture paradoxically indicates an estrogen dependent tumor that will respond to antiestrogenic therapy. Another sample of tumor cells is cultured in the presence of a chemotherapeutic agent which predicts response of the tumor to in vivo administration of a cytotoxic agent. The chemotherapeutic agent is preferably a cytotoxic drug, or a drug having both cytotoxic and antiestrogenic mechanisms of action. A particularly suitable substance having both mechanisms of action is (I): wherein R1 is H, OH, OOC(CH2)2CO2H or CH3COO; R2 is C6H4OH, C6H4OCOCH3, C6H4OOC(CH2)CO2H, or C6H5; and X is C6H3-2,4(NO2)2, C6H5, C6H4-4(NO2), C6H4-3(NO2), or C6H3-2,4(NO2)2. Predictive power of the assay is increased by combining information from the estradiol and chemotherapeutic assays. These assays are preferably performed in culture flasks having removable bases that function as conventional microscope slides.
Morgan Lee R.
Oyen Wiggs Green & Mutala Llp
LandOfFree
Method of predicting tumor response to therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of predicting tumor response to therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of predicting tumor response to therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1759042